Form 8-K UiPath, Inc. For: Mar 15

Go back to Form 8-K UiPath, Inc. For: Mar 15

Oppenheimer Remains Sidelined on UiPath Inc. (PATH), 'FY2024 ARR guidance implies that this reported metric will continue declining and remains a stock overhang'

March 16, 2023 5:17 AM EDT

Oppenheimer analyst Brian Schwartz reiterated a Perform rating and {REMOVEPT} price target on UiPath Inc. (NYSE: PATH).

The analyst comments "UiPaths F4Q results and operating margin guidance were above Street expectations, consistent with our preview. We believe UiPaths business has... More